https://endpts.com/bristol-myers-2seventy-roll-out-full-abecma-data-in-earlier-stage-cancer/
0
0
2/10/23 at 12:34pm
Organization
Endpoints News
Author
Paul Schloesser
63 words
0
Comments
Bristol Myers Squibb and 2seventy bio teased a top-line win for their BCMA-targeting CAR-T Abecma in earlier stages of multiple myeloma back in August. Now they're offering a look at the full data. The biotech and Big Pharma pair put out word Friday that rela…
You are the first to view
Create an account
or login to join the discussion